EPHX2 and cardiovascular disorder: Based on these features, diflapolin might be a valuable chemical tool for studying the biology of FLAP and sEH, particularly as synergizing targets, and may represent a useful lead for evaluation of the therapeutic potential of dual FLAP and sEH inhibition in inflammatory and cardiovascular disorders.